| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/0009-2797(90)90106-W |
| P698 | PubMed publication ID | 2406032 |
| P2093 | author name string | Docampo R | |
| P433 | issue | 1 | |
| P304 | page(s) | 1-27 | |
| P577 | publication date | 1990-01-01 | |
| P1433 | published in | Chemico-biological Interactions | Q14923137 |
| P1476 | title | Sensitivity of parasites to free radical damage by antiparasitic drugs | |
| P478 | volume | 73 |
| Q34596630 | A clinical adverse drug reaction prediction model for patients with chagas disease treated with benznidazole |
| Q44961542 | A comparative study of albendazole and mebendazole-induced, time-dependent oxidative stress |
| Q36371444 | A key role for old yellow enzyme in the metabolism of drugs by Trypanosoma cruzi |
| Q36516224 | A mechanism for cross-resistance to nifurtimox and benznidazole in trypanosomes |
| Q39307673 | A unique cascade of oxidoreductases catalyses trypanothione-mediated peroxide metabolism in Crithidia fasciculata |
| Q40290159 | Activity of the new triazole derivative albaconazole against Trypanosoma (Schizotrypanum) cruzi in dog hosts |
| Q35352651 | An antioxidant response is involved in resistance of Giardia duodenalis to albendazole |
| Q38017721 | Antiparasitical chemotherapy in Chagas' disease cardiomyopathy: current evidence |
| Q40919170 | Benznidazole, a drug employed in the treatment of Chagas' disease, down-regulates the synthesis of nitrite and cytokines by murine stimulated macrophages |
| Q39594370 | Biochemical characterization of a trypanosome enzyme with glutathione-dependent peroxidase activity |
| Q37273355 | CYP51: A major drug target in the cytochrome P450 superfamily |
| Q37670897 | Challenges in the chemotherapy of Chagas disease: Looking for possibilities related to the differences and similarities between the parasite and host |
| Q35569065 | Chemotherapy of human African trypanosomiasis: current and future prospects |
| Q42687987 | Cloning, expression and reconstitution of the trypanothione-dependent peroxidase system of Crithidia fasciculata |
| Q28486220 | Combined approaches for drug design points the way to novel proline racemase inhibitor candidates to fight Chagas' disease |
| Q35260409 | Crystal structure of 4-[(E)-(4-nitro-benzyl-idene)amino]-phenol |
| Q37855843 | Current and future perspectives on the chemotherapy of the parasitic protozoa Trichomonas vaginalis and Entamoeba histolytica. |
| Q37879205 | Current status of Chagas disease chemotherapy. |
| Q39367366 | Deletion of the Trypanosoma brucei superoxide dismutase gene sodb1 increases sensitivity to nifurtimox and benznidazole. |
| Q38845466 | Detection and treatment of Trypanosoma cruzi: a patent review (2011-2015). |
| Q39594361 | Distinct mitochondrial and cytosolic enzymes mediate trypanothione-dependent peroxide metabolism in Trypanosoma cruzi |
| Q36711411 | Drug antioxidant effects. A basis for drug selection? |
| Q50521532 | Effects of infection intensity with Strongyloides papillosus and albendazole treatment on development of oxidative/nitrosative stress in sheep |
| Q43276756 | Ergosterol biosynthesis and drug development for Chagas disease |
| Q42623496 | Evidence for a trypanothione-dependent peroxidase system in Trypanosoma cruzi |
| Q41989175 | Experimental and Clinical Treatment of Chagas Disease: A Review. |
| Q34647009 | Genetic dissection of drug resistance in trypanosomes |
| Q33777935 | Glutathione and trypanothione in parasitic hydroperoxide metabolism |
| Q35224465 | Interactions between immunity and chemotherapy in the treatment of the trypanosomiases and leishmaniases |
| Q36080155 | Intraspecies variation in Trypanosoma cruzi GPI-mucins: biological activities and differential expression of α-galactosyl residues. |
| Q42470922 | Liver microsomal biotransformation of nitro-aryl drugs: mechanism for potential oxidative stress induction. |
| Q43719599 | Molecular characterisation of mitochondrial and cytosolic trypanothione-dependent tryparedoxin peroxidases in Trypanosoma brucei |
| Q46238977 | Molecular characterization of cytosolic and mitochondrial tryparedoxin peroxidase in Trypanosoma cruzi populations susceptible and resistant to benznidazole |
| Q38857317 | Molecular characterization of the trypanothione reductase gene from Crithidia fasciculata and Trypanosoma brucei: comparison with other flavoprotein disulphide oxidoreductases with respect to substrate specificity and catalytic mechanism |
| Q36867785 | Molecular cloning and characterization of two iron superoxide dismutase cDNAs from Trypanosoma cruzi |
| Q33870409 | Nitric oxide donor trans-[RuCl([15]aneN)NO] as a possible therapeutic approach for Chagas' disease |
| Q73871276 | Nitro aryl 1,4-dihydropyridine derivatives: effects on Trypanosoma cruzi |
| Q58846994 | Nitrofuran drugs as common subversive substrates of Trypanosoma cruzi lipoamide dehydrogenase and trypanothione reductase |
| Q40394480 | Novel 3-nitro-1H-1,2,4-triazole-based aliphatic and aromatic amines as anti-chagasic agents |
| Q39355235 | Novel 3-nitro-1H-1,2,4-triazole-based amides and sulfonamides as potential antitrypanosomal agents |
| Q39516712 | Overexpression of superoxide dismutase in Trypanosoma cruzi results in increased sensitivity to the trypanocidal agents gentian violet and benznidazole |
| Q37363965 | Pediatric clinical pharmacology studies in Chagas disease: focus on Argentina |
| Q35431209 | Peptide Inhibition of Topoisomerase IB from Plasmodium falciparum |
| Q39127504 | Phenotype of recombinant Leishmania donovani and Trypanosoma cruzi which over-express trypanothione reductase. Sensitivity towards agents that are thought to induce oxidative stress. |
| Q36588449 | Preparation, crystallization and preliminary crystallographic analysis of old yellow enzyme from Trypanosoma cruzi |
| Q24676196 | Purification of glutathionylspermidine and trypanothione synthetases from Crithidia fasciculata |
| Q37870316 | Recommendations for management of Chagas disease in organ and hematopoietic tissue transplantation programs in nonendemic areas. |
| Q72955229 | Role of reactive oxygen species in expulsion of Nippostrongylus brasiliensis from rats |
| Q32111074 | Sequence analysis of the tryparedoxin peroxidase gene from Crithidia fasciculata and its functional expression in Escherichia coli |
| Q42685244 | Sequence, heterologous expression and functional characterization of a novel tryparedoxin from Crithidia fasciculata |
| Q47977281 | Sequence, heterologous expression and functional characterization of tryparedoxin1 from Crithidia fasciculata |
| Q35569069 | Specific chemotherapy of Chagas disease: controversies and advances |
| Q34416239 | Structure of the inhibitor complex of old yellow enzyme from Trypanosoma cruzi |
| Q68262192 | Superoxide dismutases in Eimeria tenella |
| Q35237566 | Target validation: linking target and chemical properties to desired product profile |
| Q39594356 | TcGPXII, a glutathione-dependent Trypanosoma cruzi peroxidase with substrate specificity restricted to fatty acid and phospholipid hydroperoxides, is localized to the endoplasmic reticulum |
| Q35129255 | The Role of Glutathione Peroxidases in Trypanosomatids |
| Q46510768 | The characterization of anti-T. cruzi activity relationships between ferrocenyl, cyrhetrenyl complexes and ROS release. |
| Q37597063 | The effects of nitric oxide on the immune system during Trypanosoma cruzi infection |
| Q27619480 | The high resolution crystal structure of recombinant Crithidia fasciculata tryparedoxin-I |
| Q46350947 | The level of ascorbate peroxidase is enhanced in benznidazole-resistant populations of Trypanosoma cruzi and its expression is modulated by stress generated by hydrogen peroxide. |
| Q34283369 | The metabolism and mode of action of gentian violet |
| Q46861067 | The pentose phosphate pathway in Trypanosoma cruzi: a potential target for the chemotherapy of Chagas disease |
| Q46558491 | Trypanocidal activity of N-isopropyl oxamate on cultured epimastigotes and murine trypanosomiasis using different Trypanosoma cruzi strains |
| Q52618288 | Trypanocidal activity of ergosterol peroxide from Pleurotus ostreatus. |
| Q37623081 | Trypanocidal drugs: mechanisms, resistance and new targets |
| Q34128482 | Trypanosoma cruzi gene expression in response to gamma radiation |
| Q41884826 | Trypanosoma cruzi: antiproliferative effect of indole phytoalexins on intracellular amastigotes in vitro |
| Q34118095 | Uptake and mode of action of drugs used against sleeping sickness. |
Search more.